natgillin/translations-raw huggingface dataset:
Diovan Comp og tilhørende navne (se bilag I) 80 mg/12,5 mg filmovertrukne tabletter Diovan Comp og tilhørende navne (se bilag I) 160 mg/12,5 mg filmovertrukne tabletter Diovan Comp og tilhørende navne (se bilag I) 160 mg/25 mg filmovertrukne tabletter Diovan Comp og tilhørende navne (se bilag I) 320 mg/12,5 mg filmovertrukne tabletter Diovan Comp og tilhørende navne (se bilag I) 320 mg/25 mg filmovertrukne tabletter [Se Bilag I - Udfyldes nationalt] 
Diovan Comp and associated names (see Annex I) 80 mg/12.5 mg film-coated tablets Diovan Comp and associated names (see Annex I) 160 mg/12.5 mg film-coated tablets Diovan Comp and associated names (see Annex I) 160 mg/25 mg film-coated tablets Diovan Comp and associated names (see Annex I) 320 mg/12.5 mg film-coated tablets Diovan Comp and associated names (see Annex I) 320 mg/25 mg film-coated tablets [See Annex I - To be completed nationally]
Desuden responderede en signifikant højere procentdel af patienterne (diastolisk blodtryk <90 mmHg eller reduktion ≥10 mmHg) med valsartan/hydrochlorthiazid 160/25 mg (81 %) og valsartan/hydrochlorthiazid 160/12,5 mg (76 %) sammenlignet med placebo (29 %) og de respektive monoterapier, dvs. hydrochlorthiazid 12,5 mg (41 %), hydrochlorthiazid 25 mg (54 %) og valsartan 160 mg (59 %). 
In addition, a significantly greater percentage of patients responded (diastolic BP <90 mmHg or reduction ≥10 mmHg) with valsartan/hydrochlorothiazide 160/25 mg (81%) and valsartan/ hydrochlorothiazide 160/12.5 mg (76%) compared to placebo (29%) and the respective monotherapies, i.e. hydrochlorothiazide 12.5 mg (41%), hydrochlorothiazide 25 mg (54%), and valsartan 160 mg (59%).
Kontakt lægen, skadestuen eller apoteket, hvis du er kommet til at tage for mange tabletter. 
If you have accidentally taken too many tablets, contact your doctor, pharmacist or hospital.
I et dobbeltblindt, randomiseret, placebo-kontrolleret faktorforsøg til sammenligning af forskellige dosiskombinationer af valsartan/hydrochlorthiazid i forhold til deres respektive komponenter sås signifikant større middelreduktioner i systolisk/diastolisk blodtryk med kombinationen valsartan/hydrochlorthiazid 160/12,5 mg (17,8/13,5 mmHg) og 160/25 mg (22,5/15,3 mmHg) sammenlignet med placebo (1,9/4,1 mmHg) og de respektive monoterapier, dvs. hydrochlorthiazid 12,5 mg (7,3/7,2 mmHg), hydrochlorthiazid 25 mg (12,7/9,3 mmHg) og valsartan 160 mg (12,1/9,4 mmHg). 
In a double-blind, randomised, placebo-controlled, factorial design trial comparing various dose combinations of valsartan/hydrochlorothiazide to their respective components, significantly greater mean systolic/diastolic BP reductions were observed with the combination of valsartan/hydrochlorothiazide 160/12.5 mg (17.8/13.5 mmHg) and 160/25 mg (22.5/15.3 mmHg) compared to placebo (1.9/4.1 mmHg) and the respective monotherapies, i.e., hydrochlorothiazide 12.5 mg (7.3/7.2 mmHg), hydrochlorothiazide 25 mg (12.7/9.3 mmHg) and valsartan 160 mg (12.1/9.4 mmHg).
Desuden responderede en signifikant højere procentdel af patienterne (diastolisk blodtryk <90 mmHg eller reduktion ≥10 mmHg) med valsartan/hydrochlorthiazid 320/25 mg (75 %) og 320/12,5 mg (69 %) sammenlignet med valsartan 320 mg (53 %). 
In addition, a significantly greater percentage of patients responded (diastolic BP <90 mmHg or reduction ≥10 mmHg) with valsartan/hydrochlorothiazide 320/25 mg (75%) and 320/12.5 mg (69%) compared to valsartan 320 mg (53%).
Desuden responderede en signifikant højere procentdel af patienterne (diastolisk blodtryk <90 mmHg eller reduktion ≥10 mmHg) med valsartan/hydrochlorthiazid 80/12,5 mg (64 %) sammenlignet med placebo (29 %) og hydrochlorthiazid (41 %). 
In addition, a significantly greater percentage of patients responded (diastolic BP <90 mmHg or reduction ≥10 mmHg) with valsartan/hydrochlorothiazide 80/12.5 mg (64%) compared to placebo (29%) and hydrochlorothiazide (41%).
Kontraststoffer med iod 
Iodine contrast media
I et dobbeltblindt, randomiseret, aktiv-kontrolleret forsøg med patienter, der ikke responderede tilstrækkeligt på valsartan 160 mg, sås signifikant større middelreduktioner i systolisk/diastolisk blodtryk med både kombinationen valsartan/hydrochlorthiazid 160/25 mg (14,6/11,9 mmHg) og valsartan/hydrochlorthiazid 160/12,5 mg (12,4/10,4 mmHg) sammenlignet med valsartan 160 mg (8,7/8,8 mmHg). 
In a double-blind, randomised, active-controlled trial in patients not adequately controlled on valsartan 160 mg, significantly greater mean systolic/diastolic BP reductions were observed with both the combination of valsartan/hydrochlorothiazide 160/25 mg (14.6/11.9 mmHg) and valsartan/hydrochlorothiazide 160/12.5 mg (12.4/10.4 mmHg) compared to valsartan 160 mg (8.7/8.8 mmHg).
I et dobbeltblindt, randomiseret, aktiv-kontrolleret forsøg med patienter, der ikke responderede tilstrækkeligt på valsartan 320 mg, sås signifikant større middelreduktioner i systolisk/diastolisk blodtryk med både kombinationen valsartan/hydrochlorthiazid 320/25 mg (15,4/10,4 mmHg) og valsartan/hydrochlorthiazid 320/12,5 mg (13,6/9,7 mmHg) sammenlignet med valsartan 320 mg (6,1/5,8 mmHg). 
In a double-blind, randomised, active-controlled trial in patients not adequately controlled on valsartan 320 mg, significantly greater mean systolic/diastolic BP reductions were observed with both the combination of valsartan/hydrochlorothiazide 320/25 mg (15.4/10.4 mmHg) and valsartan/hydrochlorothiazide 320/12.5 mg (13.6/9.7 mmHg) compared to valsartan 320 mg (6.1/5.8 mmHg).
Diovan Comp og tilhørende navne (se bilag I) 80 mg/12,5 mg filmovertrukne tabletter Diovan Comp og tilhørende navne (se bilag I) 160 mg/12,5 mg filmovertrukne tabletter Diovan Comp og tilhørende navne (se bilag I) 160 mg/25 mg filmovertrukne tabletter Diovan Comp og tilhørende navne (se bilag I) 320 mg/12,5 mg filmovertrukne tabletter Diovan Comp og tilhørende navne (se bilag I) 320 mg/25 mg filmovertrukne tabletter Valsartan/hydrochlorthiazid 
Diovan Comp and associated names (see Annex I) 80 mg/12.5 mg film-coated tablets Diovan Comp and associated names (see Annex I) 160 mg/12.5 mg film-coated tablets Diovan Comp and associated names (see Annex I) 160 mg/25 mg film-coated tablets Diovan Comp and associated names (see Annex I) 320 mg/12.5 mg film-coated tablets Diovan Comp and associated names (see Annex I) 320 mg/25 mg film-coated tablets Valsartan/hydrochlorothiazide
Af hensyn til miljøet må du ikke smide medicinrester i afløbet, toilettet eller skraldespanden. 
• Medicines should not be disposed of via wastewater or household waste.
Indehaver af markedsføringstilladelsen og fremstiller [Se bilag I - Udfyldes nationalt] 
Marketing Authorisation Holder and Manufacturer [See Annex I - To be completed nationally]
Diovan Comp og tilhørende navne (se bilag I) 80 mg/12,5 mg filmovertrukne tabletter Diovan Comp og tilhørende navne (se bilag I) 160 mg/12,5 mg filmovertrukne tabletter Diovan Comp og tilhørende navne (se bilag I) 160 mg/25 mg filmovertrukne tabletter Diovan Comp og tilhørende navne (se bilag I) 320 mg/12,5 mg filmovertrukne tabletter Diovan Comp og tilhørende navne (se bilag I) 320 mg/25 mg filmovertrukne tabletter [Se bilag I - Udfyldes nationalt] Valsartan/hydrochlorthiazid 
Diovan Comp and associated names (see Annex I) 80 mg/12.5 mg film-coated tablets Diovan Comp and associated names (see Annex I) 160 mg/12.5 mg film-coated tablets Diovan Comp and associated names (see Annex I) 160 mg/25 mg film-coated tablets Diovan Comp and associated names (see Annex I) 320 mg/12.5 mg film-coated tablets Diovan Comp and associated names (see Annex I) 320 mg/25 mg film-coated tablets [See Annex I - To be completed nationally] Valsartan/hydrochlorothiazide
I et dobbeltblindt, randomiseret, aktiv-kontrolleret forsøg med patienter, der ikke responderede tilstrækkeligt på valsartan 80 mg, sås signifikant større middelreduktioner i systolisk/diastolisk blodtryk med kombinationen valsartan/hydrochlorthiazid 80/12,5 mg (9,8/8,2 mmHg) sammenlignet med valsartan 80 mg (3,9/5,1 mmHg) og valsartan 160 mg (6,5/6,2 mmHg). 
In a double-blind, randomised, active-controlled trial in patients not adequately controlled on valsartan 80 mg, significantly greater mean systolic/diastolic BP reductions were observed with the combination of valsartan/hydrochlorothiazide 80/12.5 mg (9.8/8.2 mmHg) compared to valsartan 80 mg (3.9/5.1 mmHg) and valsartan 160 mg (6.5/6.2 mmHg).
Sverige 
Spain
Desuden responderede en signifikant højere procentdel af patienterne (diastolisk blodtryk <90 mmHg eller reduktion ≥10 mmHg) med valsartan/hydrochlorthiazid 160/25 mg (68 %) og 160/12,5 mg (62 %) sammenlignet med valsartan 160 mg (49 %). 
In addition, a significantly greater percentage of patients responded (diastolic BP <90 mmHg or reduction ≥10 mmHg) with valsartan/hydrochlorothiazide 160/25 mg (68%) and 160/12.5 mg (62%) compared to valsartan 160 mg (49%).
Desuden responderede en signifikant højere procentdel af patienterne (diastolisk blodtryk <90 mmHg eller reduktion ≥10 mmHg) med valsartan/hydrochlorthiazid 80/12,5 mg (51 %) sammenlignet med valsartan 80 mg (36 %) og valsartan 160 mg (37 %). 
In addition, a significantly greater percentage of patients responded (diastolic BP <90 mmHg or reduction ≥10 mmHg) with valsartan/hydrochlorothiazide 80/12.5 mg (51%) compared to valsartan 80 mg (36%) and valsartan 160 mg (37%).
Cordinate plus 80/12.5 mg 80 mg / 12,5 mg Filmovertrukne tabletter 
Cordinate plus 80/12.5 mg 80 mg / 12.5 mg film-coated tablets oral
I et dobbeltblindt, randomiseret, placebo-kontrolleret faktorforsøg til sammenligning af forskellige dosiskombinationer af valsartan/hydrochlorthiazid i forhold til deres respektive komponenter sås signifikant større middelreduktioner i systolisk/diastolisk blodtryk med kombinationen valsartan/hydrochlorthiazid 320/12,5 mg (21,7/15,0 mmHg) og 320/25 mg (24,7/16,6 mmHg) sammenlignet med placebo (7,0/5,9 mmHg) og de respektive monoterapier, dvs. hydrochlorthiazid 12,5 mg (11,1/9,0 mmHg), hydrochlorthiazid 25 mg (14,5/10,8 mmHg) og valsartan 320 mg (13,7/11,3 mmHg). 
In a double-blind, randomised, placebo-controlled, factorial design trial comparing various dose combinations of valsartan/hydrochlorothiazide to their respective components, significantly greater mean systolic/diastolic BP reductions were observed with the combination of valsartan/hydrochlorothiazide 320/12.5 mg (21.7/15.0 mmHg) and 320/25 mg (24.7/16.6 mmHg) compared to placebo (7.0/5.9 mmHg) and the respective monotherapies, i.e. hydrochlorothiazide 12.5 mg (11.1/9.0 mmHg), hydrochlorothiazide 25 mg (14.5/10.8 mmHg) and valsartan 320 mg (13.7/11.3 mmHg).
Co-Dalzad (160+25) mg 160 mg / 25 mg Filmovertrukne tabletter 
Co-Dalzad (160+25) mg 160 mg / 25 mg film-coated tablets oral
Desuden responderede en signifikant højere procentdel af patienterne (diastolisk blodtryk <90 mmHg eller reduktion ≥10 mmHg) med valsartan/hydrochlorthiazid 80/12,5 mg (60 %) sammenlignet med hydrochlorthiazid 12,5 mg (25 %) og hydrochlorthiazid 25 mg (27 %). 
In addition, a significantly greater percentage of patients responded (diastolic BP <90 mmHg or reduction ≥10 mmHg) with valsartan/hydrochlorothiazide 80/12.5 mg (60%) compared to hydrochlorothiazide 12.5 mg (25%) and hydrochlorothiazide 25 mg (27%).
I et dobbeltblindt, randomiseret, placebo-kontrolleret faktorforsøg til sammenligning af forskellige dosiskombinationer af valsartan/hydrochlorthiazid i forhold til deres respektive komponenter sås signifikant større middelreduktioner i systolisk/diastolisk blodtryk med kombinationen valsartan/hydrochlorthiazid 80/12,5 mg (16,5/11,8 mmHg) sammenlignet med placebo (1,9/4,1 mmHg) og både hydrochlorthiazid 12,5 mg (7,3/7,2 mmHg) og valsartan 80 mg (8,8/8,6 mmHg). 
In a double-blind, randomised, placebo-controlled, factorial design trial comparing various dose combinations of valsartan/hydrochlorothiazide to their respective components, significantly greater mean systolic/diastolic BP reductions were observed with the combination of valsartan/hydrochlorothiazide 80/12.5 mg (16.5/11.8 mmHg) compared to placebo (1.9/4.1 mmHg) and both hydrochlorothiazide 12.5 mg (7.3/7.2 mmHg) and valsartan 80 mg (8.8/8.6 mmHg).
Co- Novacard 80/12.5 mg 80 mg / 12,5 mg Filmovertrukne tabletter 
Co- Novacard 80/12.5 mg 80 mg / 12.5 mg film-coated tablets oral
Co-Dalzad (160+12.5) mg 160 mg / 12,5 mg Filmovertrukne tabletter 
Co-Dalzad (160+12.5) mg 160 mg / 12,5 mg film-coated tablets oral
Cordinate plus 160/12.5 mg 160 mg / 12,5 mg Filmovertrukne tabletter 
Cordinate plus 160/12.5 mg 160 mg / 12.5 mg film-coated tablets oral
Hos rotter repræsenterede disse doser henholdsvis 3,0 og 12 gange den maksimale anbefalede humane dosis af valsartan og hydrochlorthiazid udtrykt i mg/m2. 
These doses in rat, respectively, represent 3.0 and 12 times the maximum recommended human dose (MRHD) of valsartan and hydrochlorothiazide on a mg/m2 basis.
Co-Dalzad (80+12.5) mg 80 mg / 12,5 mg Filmovertrukne tabletter 
Co-Dalzad (80+12.5) mg 80 mg / 12,5 mg film-coated tablets oral
Knogler, led, muskler og bindevæv Ikke almindelig 
Musculoskeletal and connective tissue disorders Uncommon
Cordinate plus 320/12.5 mg 320 mg / 12,5 mg Filmovertrukne tabletter 
Cordinate plus 320/12.5 mg 320 mg / 12.5 mg film-coated tablets oral
Cotareg 160mg/25 mg 160 mg / 25 mg Filmovertrukne tabletter 
Cotareg 160mg/25 mg 160 mg / 25 mg film-coated tablets oral
Co-Dalzad (320+25) mg 320 mg / 25 mg Filmovertrukne tabletter 
Co-Dalzad (320+25) mg 320 mg / 25 mg film-coated tablets oral
Hver filmovertrukken tablet indeholder 320 mg valsartan og 25 mg hydrochlorthiazid. 
Each film-coated tablet contains 320 mg valsartan and 25 mg hydrochlorothiazide.
• stikken/prikken eller følelsesløshed 
• tingling or numbness
Co- Novacard 160/25 mg 160 mg / 25 mg Filmovertrukne tabletter 
Co- Novacard 160/25 mg 160 mg / 25 mg film-coated tablets oral
Co-Dalzad (320+12.5) mg 320 mg / 12,5 mg Filmovertrukne tabletter 
Co-Dalzad (320+12.5) mg 320 mg / 12,5 mg film-coated tablets oral
I et dobbeltblindt, randomiseret, aktiv-kontrolleret forsøg med patienter, der ikke responderede tilstrækkeligt på hydrochlorthiazid 12,5 mg, sås signifikant større middelreduktioner i systolisk/diastolisk blodtryk med kombinationen valsartan/hydrochlorthiazid 80/12,5 mg (14,9/11,3 mmHg) sammenlignet med hydrochlorthiazid 12,5 mg (5,2/2,9 mmHg) og hydrochlorthiazid 25 mg (6,8/5,7 mmHg). 
In a double-blind, randomised, active-controlled trial in patients not adequately controlled on hydrochlorothiazide 12.5 mg, significantly greater mean systolic/diastolic BP reductions were observed with the combination of valsartan/hydrochlorothiazide 80/12.5 mg (14.9/11.3 mmHg) compared to hydrochlorothiazide 12.5 mg (5.2/2.9 mmHg) and hydrochlorothiazide 25 mg
• nyresvigt 
• dizziness
Co- Novacard 160/12.5 mg 160 mg / 12,5 mg Filmovertrukne tabletter 
Co- Novacard 160/12.5 mg 160 mg / 12.5 mg film-coated tablets oral
Diovan Comp 160/12.5 mg 160 mg / 12,5 mg Filmovertrukne tabletter 
Diovan Comp 160/12.5 mg 160 mg / 12.5 mg film-coated tablets oral
Valsartan er i høj grad bundet til plasmaprotein og fjernes ikke ved dialyse, mens clearance af hydrochlorthiazid vil kunne øges ved dialyse. 
In patients with severe renal impairment (creatinine clearance <30 ml/min) and patients undergoing dialysis no data are available for Diovan Comp. Valsartan is highly bound to plasma protein and is not to be removed by dialysis, whereas clearance of hydrochlorothiazide will be achieved by dialysis.
Hver tablet indeholder 320 mg valsartan og 25 mg hydrochlorthiazid. 
Each tablet contains 320 mg of valsartan and 25 mg of hydrochlorothiazide.
Hver filmovertrukken tablet indeholder 160 mg valsartan og 25 mg hydrochlorthiazid. 
Each film-coated tablet contains 160 mg valsartan and 25 mg hydrochlorothiazide.
Cotareg 160mg/12.5 mg 160 mg / 12,5 mg Filmovertrukne tabletter 
Cotareg 160mg/12.5 mg 160 mg / 12.5 mg film-coated tablets oral
Cotareg 80mg/12.5 mg 80 mg / 12,5 mg Filmovertrukne tabletter 
Cotareg 80mg/12.5 mg 80 mg / 12.5 mg film-coated tablets oral
Diovan Comp 320/12.5 mg 320 mg / 12,5 mg Filmovertrukne tabletter 
Diovan Comp 320/12.5 mg 320 mg / 12.5 mg film-coated tablets oral
• ledsmerter 
• light-headedness
Slovenien Novartis Pharma GmbH Roonstrasse 25 
Slovenia Novartis Pharma GmbH Roonstrasse 25
Hver tablet indeholder 160 mg valsartan og 25 mg hydrochlorthiazid. 
Each tablet contains 160 mg of valsartan and 25 mg of hydrochlorothiazide.
Hver filmovertrukken tablet indeholder 320 mg valsartan og 12,5 mg hydrochlorthiazid. 
Each film-coated tablet contains 320 mg valsartan and 12.5 mg hydrochlorothiazide.
Co-Diovane 80/12.5 mg 160 mg / 12,5 mg Filmovertrukne tabletter 
Co-Diovane 80/12,5 mg 160 mg / 12.5 mg film-coated tablets oral
Hver tablet indeholder 320 mg valsartan og 12,5 mg hydrochlorthiazid. 
Each tablet contains 320 mg of valsartan and 12.5 mg of hydrochlorothiazide.
Desuden responderede en signifikant højere procentdel af patienterne (blodtryk <140/90 mmHg eller reduktion i systolisk blodtryk ≥20 mmHg eller reduktion i diastolisk blodtryk ≥10 mmHg ) med valsartan/hydrochlorthiazid 160/12,5 mg (50 %) sammenlignet med hydrochlorthiazid 25 mg (25 %). 
In addition, a significantly greater percentage of patients responded (BP <140/90 mmHg or SBP reduction ≥20 mmHg or DBP reduction ≥10 mmHg) with valsartan/hydrochlorothiazide 160/12.5 mg (50%) compared to hydrochlorothiazide 25 mg (25%).
Hver filmovertrukken tablet indeholder 160 mg valsartan og 12,5 mg hydrochlorthiazid. 
Each film-coated tablet contains 160 mg valsartan and 12.5 mg hydrochlorothiazide.
Diovan Comp bør anvendes med forsigtighed til patienter med mild til moderat leverinsufficiens uden cholestasis (se pkt. 
In patients with mild to moderate hepatic impairment without cholestasis, Diovan Comp should be used with caution (see sections 4.2 and 5.2).
Co-Diovan (160 + 25 mg) 160 mg / 25 mg Filmovertrukne tabletter 
Co-Diovan (160 + 25 mg) 160 mg / 25 mg film-coated tablets oral
Co-Diovan (320 + 25 mg) 320 mg / 25 mg Filmovertrukne tabletter 
Co-Diovan (320 + 25 mg) 320 mg / 25 mg film-coated tablets oral
Hver filmovertrukken tablet indeholder 80 mg valsartan og 12,5 mg hydrochlorthiazid. 
Each film-coated tablet contains 80 mg valsartan and 12.5 mg hydrochlorothiazide.
Hos rotter repræsenterede disse doser henholdsvis 0,9 og 3,5 gange den maksimale anbefalede humane dosis af valsartan og hydrochlorthiazid udtrykt i mg/m2. 
These doses in rat, respectively, represent 0.9 and 3.5-times the maximum recommended human dose (MRHD) of valsartan and hydrochlorothiazide on a mg/m2 basis.
CORIXIL 160/12.5 mg 160 mg / 12,5 mg Filmovertrukne tabletter 
CORIXIL 160/12.5 mg 160 mg / 12.5 mg film-coated tablets oral
Hver tablet indeholder 160 mg valsartan og 12,5 mg hydrochlorthiazid. 
Each tablet contains 160 mg of valsartan and 12.5 mg of hydrochlorothiazide.
Co-Diovan (160 + 12.5 mg) 160 mg / 12,5 mg Filmovertrukne tabletter 
Co-Diovan (160 + 12.5 mg) 160 mg / 12.5 mg film-coated tablets oral
Co-Diovan (80 + 12.5 mg) 80 mg / 12,5 mg Filmovertrukne tabletter 
Co-Diovan (80 + 12.5 mg) 80 mg / 12.5 mg film-coated tablets oral
Overfølsomhedsreaktioner 
Hypersenstivity reactions
Co-Diovan (320 + 12.5 mg) 320 mg / 12,5 mg Filmovertrukne tabletter 
Co-Diovan (320 + 12.5 mg) 320 mg / 12.5 mg film-coated tablets oral
Co-Diovan forte 160/25 mg 160 mg / 25 mg Filmovertrukne tabletter 
Co-Diovan forte 160/25 mg 160 mg / 25 mg film-coated tablets oral
Co-Diovan (160+25) mg 160 mg / 25 mg Filmovertrukne tabletter 
Co-Diovan (160+25) mg 160 mg / 25 mg film-coated tablets oral
Hver tablet indeholder 80 mg valsartan og 12,5 mg hydrochlorthiazid. 
Each tablet contains 80 mg of valsartan and 12.5 mg of hydrochlorothiazide.
Comp. 
Cough
Co-Diovan (160+12.5) mg 160 mg / 12,5 mg Filmovertrukne tabletter 
Co-Diovan (160+12,5) mg 160 mg / 12,5 mg film-coated tablets oral
Co-Diovan (80+12.5) mg 80 mg / 12,5 mg Filmovertrukne tabletter 
Co-Diovan (80+12,5) mg 80 mg / 12,5 mg film-coated tablets oral
Tyskland Novartis Pharma GmbH Roonstrasse 25 
Germany Novartis Pharma GmbH Roonstrasse 25
• Lægen har ordineret Diovan Comp til dig personligt. 
• This medicine has been prescribed for you.
Co-Diovan (320+25) mg 320 mg / 25 mg Filmovertrukne tabletter 
Co-Diovan (320+25) mg 320 mg / 25 mg film-coated tablets oral
Den kliniske reaktion på Diovan Comp bør evalueres efter påbegyndelse af terapien, og hvis blodtrykket stadig ikke kan kontrolleres, kan dosis øges ved at øge mængden af en af komponenterne til en maksimumdosis Diovan Comp 320 mg/25 mg." Det tredje spørgsmål, der blev diskuteret, drejede sig om, at den gensidige anerkendelsesprocedure for produktresuméer begrænser anvendelsen af både valsartan/HCTZ 160/25 og 320/25 mg hos patienter, hvis gennemsnitlige diastoliske blodtryk i siddende stilling er > 100 mmHg. 
The clinical response to Diovan Comp should be evaluated after initiating therapy and if blood pressure remains uncontrolled, the dose may be increased by increasing either one of the components to a maximum dose of Diovan Comp 320 mg/25 mg”
Storbritannien Novartis Pharmaceuticals UK Ltd Trading as Ciba Laboratories Frimley Business Park 
Novartis Pharmaceuticals UK Ltd Trading as Ciba Laboratories Frimley Business Park Frimley, Camberley Surrey GU16 7SR United Kingdom
Co-Diovan (320+12.5) mg 320 mg / 12,5 mg Filmovertrukne tabletter 
Co-Diovan (320+12,5) mg 320 mg / 12,5 mg film-coated tablets oral
Co-Diovan forte 320/25 mg 320 mg / 25 mg Filmovertrukne tabletter 
Co-Diovan forte 320/25 mg 320 mg / 25 mg film-coated tablets oral
Co-Diovan 80/12.5 mg 80 mg / 12,5 mg Filmovertrukne tabletter 
Co-Diovan 80/12.5 mg 80 mg / 12.5 mg film-coated tablets oral
Co-Diovane 160/25 mg 160 mg / 25 mg Filmovertrukne tabletter 
Co-Diovane 160/25 mg 160 mg / 25 mg film-coated tablets oral
Co-Diovane 320/12.5 mg 320 mg / 12,5 mg Filmovertrukne tabletter 
Co-Diovane 320/12.5 mg 320 mg / 12.5 mg film-coated tablets oral
Co-Diovane 160/12.5 mg 160 mg / 12,5 mg Filmovertrukne tabletter 
Co-Diovane 160/12.5 mg 160 mg / 12.5 mg film-coated tablets oral
Diovan Comp 80mg/12.5 mg80 mg / 12,5 mg Filmovertrukne tabletter 
Diovan Comp 80mg/12.5 mg80 mg / 12.5 mg film-coated tablets oral
Hos silkeaber repræsenterede disse doser henholdsvis 0,9 og 3,5 gange den maksimale anbefalede humane dosis af valsartan og hydrochlorthiazid udtrykt i mg/m2. 
These doses in marmoset, respectively, represent 0.9 and 3.5 times the maximum recommended human dose (MRHD) of valsartan and hydrochlorothiazide on a mg/m2 basis.
CO-DIOVAN 320 MG/12.5 MG FILM-COATED TABLETS 
CO-DIOVAN 320 mg/12,5 mg FILMCOATED TABLETS
Rumænien Novartis Pharma GmbH Roonstrasse 25 
Romania Novartis Pharma GmbH Roonstrasse 25
Co-Diovane 320/25 mg 320 mg / 25 mg Filmovertrukne tabletter 
Co-Diovane 320/25 mg 320 mg / 25 mg film-coated tablets oral
Estland Novartis Finland Oy Metsänneidonkuja 10 
Novartis Finland Oy Metsänneidonkuja 10 FIN-02130 Espoo
Co-Diovan 160/12.5 mg 160 mg / 12,5 mg Filmovertrukne tabletter 
Co-Diovan 160/12.5 mg 160 mg / 12.5 mg film-coated tablets oral
Diovan Comp 160mg/25 160 mg / 25 mg Filmovertrukne tabletter 
Diovan Comp 160mg/25 160 mg / 25 mg film-coated tablets oral
Diovan Comp 320 mg/25 mg320 mg / 25 mg Filmovertrukne tabletter 
Diovan Comp 320 mg/25 mg320 mg / 25 mg film-coated tablets oral
Diovan Comp 160 mg/25 mg160 mg / 25 mg Filmovertrukne tabletter 
Diovan Comp 160 mg/25 mg160 mg / 25 mg film-coated tablets oral
Diovan Comp 320mg/25 mg 320 mg / 25 mg Filmovertrukne tabletter 
Diovan Comp 320mg/25 mg 320 mg / 25 mg film-coated tablets oral
Co-Diovan 320/12.5 mg 320 mg / 12,5 mg Filmovertrukne tabletter 
Co-Diovan 320/12.5 mg 320 mg / 12.5 mg film-coated tablets oral
Diovan Comp 160/25 mg 160 mg / 25 mg Filmovertrukne tabletter 
Diovan Comp 160/25 mg 160 mg / 25 mg film-coated tablets oral
Diovan Comp 80/12.5 mg 80 mg / 12,5 mg Filmovertrukne tabletter 
Diovan Comp 80/12.5 mg 80 mg / 12.5 mg film-coated tablets oral
Diovan Comp 80 mg/12,5 mg80 mg / 12,5 mg Filmovertrukne tabletter 
Diovan Comp 80 mg/12.5 mg80 mg / 12.5 mg film-coated tablets oral
Diovan Comp 160mg/25 mg 160 mg / 25 mg Filmovertrukne tabletter 
Diovan Comp 160mg/25 mg 160 mg / 25 mg film-coated tablets oral
Co-Diovan 160/25 mg 160 mg / 25 mg Filmovertrukne tabletter 
Co-Diovan 160/25 mg 160 mg / 25 mg film-coated tablets oral